Molecular therapy of breast cancer [[electronic resource] ] : classicism meets modernity / / Marc Lacroix

• Record Nr.: UNINA9910779516303321
• Autore: Lacroix Marc <1963->
• Pubbl/distr/stampa: New York, : Nova Biomedical Books, c2009
• ISBN: 1-60876-726-4
• Descrizione fisica: 1 online resource (303 p.)
• Collana: Cancer etiology, diagnosis and treatments series
• Disciplina: 362.196/99449
• Soggetti: Breast - Cancer - Molecular aspects; Antineoplastic agents
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: ""Molecular Therapy of Breast Cancer: Classicism Meets Modernity""; ""Dedication""; ""Contents ""; ""Preface""; ""Introduction ""; ""References ""; ""Selective Estrogen Receptor Modulators (SERMs) and Down-Regulators (SERDs)""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Selective Estrogen Receptor Modifiers (SERMs) ""; ""Tamoxifen ""; ""Toremifene ""; ""Fulvestrant ""; ""Conclusion ""; ""References ""; ""Aromatase Inhibitors ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Anastrozole ""; ""Letrozole ""; ""Exemestane ""; ""Conclusion """"References ""; ""Agents Inducing Ovarian Suppression ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Goserelin ""; ""Triptorelin""; ""Leuprolide ""; ""Conclusion ""; ""References ""; ""Antimetabolites ""; ""Abstract ""; ""Introduction""; ""Clinical Trials in January 2009 ""; ""Fluorouracil ""; ""Capecitabine ""; ""Gemcitabine ""; ""Pemetrexed ""; ""Methotrexate ""; ""Conclusion ""; ""References""; ""Alkylating Agents ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Cyclophosphamide ""; ""Platinum Compounds (Cisplatin, Carboplatin, Oxaliplatin, Picoplatin) - Generalities """"Cisplatin ""; ""Carboplatin ""; ""Oxaliplatin ""; ""Picoplatin ""; ""Temozolomide ""; ""Thiotepa""; ""Ifosfamide ""; ""Melphalan ""; ""Busulfan ""; ""Conclusion ""; ""References ""; ""Anthracyclines ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Doxorubicin ""; ""Liposomal Doxorubicin ""; ""Epirubicin ""; ; ""Conclusion ""; ""References""; ""Microtubule-Binding Agents ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Taxanes - Generalities ""; ""Larotaxel """"Docetaxel ""; ""Paclitaxel and Nab-Paclitaxel ""; ""Epothilones - Generalities ""; ""Ixabepilone ""; ""Patupilone ""; ""Sagopilone ""; ""Vinca Alkaloids - Generalities ""; ""Vinorelbine""; ""Vinflunine ""; ""Eribulin ""; ""Conclusion ""; ""References ""; ""Topoisomerase Inhibitors ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Irinotecan ""; ""Etoposide ""; ""Conclusion ""; ""References""; ""HER Family Inhibitors ""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Trastuzumab ""; ""Lapatinib ""; ""Gefitinib ""; ""Erlotinib """"Pertuzumab ""; ""Cetuximab ""; ""Ertumaxomab ""; ""Neratinib ""; ""Trastuzumab-MCC-DM1 ""; ""BIBW 2992 ""; ""ARRY-334543 ""; ""Conclusion ""; ""References ""; ""Angiogenesis Inhibitors ""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Bevacizumab""; ""Sunitinib ""; ""Vandetanib ""; ""Pazopanib ""; ""Ramucirumab ""; ""ABT-869 ""; ""AV-951 ""; ""PTC299""; ""AMG 386 ""; ""Aflibercept ""; ""Conclusion""; ""References ""; ""Insulin-Like Growth Factor-I Receptor (IGF-1R) Inhibitors""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009""; ""Cixutumumab""